CMPH mener derfor, at bleomycin stadig er et værdifuldt kemoterapeutisk lægemiddel, og vedtog samtlige foreslåede indikationer for Bleomycin Pharmachemie:
Therefore the CHMP is of the opinion that bleomycin is still a valuable chemotherapeutic drug, and adopted the totality of the proposed indications, for Bleomycin Pharmachemie: